TSE:CRON - Cronos Group Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cronos Group Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$9.17 +0.26 (+2.92 %) (As of 12/9/2019 12:51 PM ET) Add Compare Today's RangeC$8.97Now: C$9.17▼C$9.4050-Day RangeC$8.05MA: C$10.10▼C$12.0852-Week RangeC$7.97Now: C$9.17▼C$32.95Volume634,172 shsAverage Volume1.46 million shsMarket CapitalizationC$3.15 billionP/E Ratio6.82Dividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations MMPR. The firm typically invests in companies based in Canada. The firm is primarily an equity investor, may also advance debt as appropriate. Read More… Industry, Sector and Symbol Stock Exchange TSE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolTSE:CRON Previous Symbol CUSIPN/A CIKN/A Webhttp://www.thecronosgroup.com/ Phone416-504-0004Debt Debt-to-Equity Ratio0.49 Current Ratio3.45 Quick Ratio3.33Price-To-Earnings Trailing P/E Ratio6.82 Forward P/E RatioN/A P/E Growth0.09 Sales & Book Value Annual SalesC$35.01 million Price / Sales90.04 Cash FlowC$6.17 per share Price / Cash Flow1.49 Book ValueC$6.25 per share Price / Book1.47Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees291 Outstanding Shares343,764,000Market CapC$3.15 billion Next Earnings DateN/A OptionableOptionable Receive CRON News and Ratings via Email Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter. TSX:CRON Rates by TradingView Cronos Group (TSE:CRON) Frequently Asked Questions What is Cronos Group's stock symbol? Cronos Group trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON." What price target have analysts set for CRON? 7 analysts have issued 12 month price targets for Cronos Group's shares. Their forecasts range from C$10.00 to C$27.00. On average, they expect Cronos Group's share price to reach C$18.56 in the next year. This suggests a possible upside of 102.4% from the stock's current price. View Analyst Price Targets for Cronos Group. What is the consensus analysts' recommendation for Cronos Group? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cronos Group. Has Cronos Group been receiving favorable news coverage? Media stories about CRON stock have been trending somewhat negative on Monday, according to InfoTrie. The research group rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cronos Group earned a media sentiment score of -1.7 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Cronos Group. Who are some of Cronos Group's key competitors? Some companies that are related to Cronos Group include MorphoSys (MOR), MorphoSys (MOR), BTG (BTG), Asterias Biotherapeutics (AST), Abcam (ABC), Kodiak Sciences (KOD), Genus (GNS), Vir Biotechnology (VIR), Clinuvel Pharmaceuticals (CUV), Concordia International (CXR), Polynovo (PNV), Mesoblast (MSB), Immutep (IMM), Paradigm Biopharmaceuticals (PAR) and BELLUS Health (BLU). What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), NVIDIA (NVDA), Aphria (APHA), Netflix (NFLX), Tilray (TLRY) and AT&T (T). Who are Cronos Group's key executives? Cronos Group's management team includes the folowing people: Mr. Michael Gorenstein, Chairman, Pres & CEO (Age 31)Mr. David Hsu, Chief Operating OfficerMs. Xiuming Shum, Gen. Counsel & Corp. Sec.Mr. Jeffrey Jacobson, Head of Sales & Bus. Devel.Mr. William Hilson, Chief Commercial Officer How do I buy shares of Cronos Group? Shares of CRON and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is Cronos Group's stock price today? One share of CRON stock can currently be purchased for approximately C$9.17. How big of a company is Cronos Group? Cronos Group has a market capitalization of C$3.15 billion and generates C$35.01 million in revenue each year. Cronos Group employs 291 workers across the globe.View Additional Information About Cronos Group. What is Cronos Group's official website? The official website for Cronos Group is http://www.thecronosgroup.com/. How can I contact Cronos Group? The company can be reached via phone at 416-504-0004. MarketBeat Community Rating for Cronos Group (TSE CRON)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 49 (Vote Outperform)Underperform Votes: 64 (Vote Underperform)Total Votes: 113MarketBeat's community ratings are surveys of what our community members think about Cronos Group and other stocks. Vote "Outperform" if you believe CRON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRON will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/9/2019 by MarketBeat.com StaffFeatured Article: What is a put option?
